Importantly, at visit 6, anti-N was positive in 27 participants, of whom 21 were patients with IBD (10 were treated with anti-TNFα, and 11 were in the non-anti-TNFα group) and 6 were HCs. The gene discussed is TNF; the disease is inflammatory bowel disease.